Frequency of Contraception Documentation in Women With Systemic Lupus Erythematosus and Rheumatoid Arthritis Within the Rheumatology Informatics System for Effectiveness Registry
Main finding · Contraception documentationResult — go to the resultAdjusted odds ratio 0.84 95% CI 0.76–0.92Authors' conclusion
There are large gaps in contraception documentation within the RISE registry that are particularly stark among women of color.
Study context
- Population
- Women of childbearing age (18–45 years) in 2018 with at least 2 visits with diagnosis codes for systemic lupus erythematosus (SLE) or rheumatoid arthritis (RA), US electronic health record (EHR)-based Rheumatology Informatics System for Effectiveness (RISE) registry
- Participants
- 9,826 vs 19,009
- Exposure
- SLE vs RA; by race and ethnicity; by teratogen prescription
- SLEn = 9,826
- RAn = 19,009reference
- Outcome
- Frequency of contraception documentation
- Follow-up
- 2018
Methodological detailsEHR-based registry, univariate and multivariate analyses
- EHR-based registry
- Univariate and multivariate analyses
Main finding
Contraception documentation
Adjusted odds ratio
0.84
95% CI 0.76–0.92
SLEvs RA
aOR 0.84 (95% CI 0.76–0.92)
As reported in the abstract
- Any contraception documented (all women)
- 9.1%
Observational data: associations, not effects.
Further findings
Contraception documentation with teratogen prescription
aOR
- Teratogen prescription, RA
- 1.31 (95% CI 1.16-1.47)
- Teratogen prescription, SLE
- 1.08 (95% CI 0.91-1.28)
Original publication
Frequency of Contraception Documentation in Women With Systemic Lupus Erythematosus and Rheumatoid Arthritis Within the Rheumatology Informatics System for Effectiveness Registry. Arthritis Care Res (Hoboken). Published 31 October 2022. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →